Welcome to Season 2 of the Spot On podcast. In Season 1, we focused on the fundamentals of skin cancer, interviewing some of Australia's leading clinicians on the topic.
In this season, we're focused more on the human side of a diagnosis.
MSCAN is thrilled to have renowned journalist Deborah Knight involved and interviewing patients about their journey with skin cancer and the road ahead.
In this episode you will hear from Professor Alan Cooper; a Clinical Dermatologist himself, who was diagnosed with stage III melanoma which progressed to stage IV. In this episode, Alan is joined by his treating clinician - Professor Georgina Long.
Professor Alan Cooper
Professor Alan Cooper was diagnosed with stage III melanoma in 2013, and despite multiple surgeries and two trials of experimental treatment it progressed to stage IV. The melanoma eventually responded to a combination of radiation therapy and immunotherapy which commenced in early 2017.
At the time of diagnosis, Alan was Clinical Professor of Dermatology at the Northern Clinical School of the University of Sydney, and Head of the Department of Dermatology at Royal North Shore Hospital. Over the years he has served in a number of capacities in The Australasian College of Dermatologists and has been involved in the training and assessment of medical students and dermatology advanced trainees. He supervised a research unit and was involved in fund raising for dermatology research through state, national and international foundations.
Alan is a Director of MSCAN.
Professor Georgina Long Professor Georgina Long is the Co-Medical Director of Melanoma Institute Australia (MIA), and Chair of Melanoma Medical Oncology and Translational Research at MIA and Royal North Shore Hospital, The University of Sydney.
She leads an extensive clinical trials team and laboratory at MIA, with a focus on targeted therapies and immuno-oncology in melanoma.
Professor Long is the author of over 370 peer-reviewed publications in clinical and translational research in melanoma.